Centene Surges on Q3 Earnings Beat and Upgraded Guidance

Centene (NYSE: CNC) shares rallied after the managed care company reported better-than-expected third-quarter results and raised its full-year guidance, signaling strong operational performance across its healthcare plans.

Q3 Results Exceed Expectations

Earnings per share (EPS): $0.50 (vs. an expected loss of $0.14 per share)
Revenue: $49.69 billion (vs. $47.72 billion expected)

The results highlight stronger membership growth, efficient cost management, and improved performance in Centene’s Medicaid and Medicare segments.

Guidance Upgrade

Following the solid quarter, Centene raised its full-year earnings guidance, reflecting continued confidence in revenue visibility and margin expansion through the rest of 2025.

Market Reaction

Investors responded positively, sending Centene shares up 10% in early trading. Analysts noted the results reaffirm Centene’s position as a key player in managed healthcare amid evolving policy and reimbursement dynamics.